FDA approves repotrectinib for ROS1-positive non-small cell lung cancer

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-repotrectinib-ros1-positive-non-small-cell-lung-cancer?utm_medium=email&utm_source=govdelivery